Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News The world's most widely read biotechnology publication. Also follow us on Twitter .

GEN's print coverage, which can easily be accessed online, includes industry-standard tutorials and technical articles in bioprocessing, assays, and drug discovery; feature articles on emerging technologies; product roundups and regional biofocus articles on biotech hotbeds; as well as reports from key scientific and industry meetings. Our acclaimed columns include Wall Street BioBeat, Point of Vi

ew, Corporate Profile, Biomarket Trends, Legal Affairs, and Best of the Web. Other regular, informative content includes New Product listings and the Calendar of Events column for bioscience and bioindustry meetings. GEN's print edition also features the following news columns: Clinical Trials Update, Genomics & Proteomics, Discovery and Development Briefs, Bioprocessing Highlights, Molecular Diagnostics, Inside Industry, Product & Service Deals, and People in the News. GEN online has additional editorial coverage including GEN News Highlights, which covers the most important stories in the life sciences on a daily basis, helping you stay current. The Analysis & Insight section is an online exclusive column that slices and dices the latest news and trends that are shaping the industry. BLOGbiotech is another online exclusive offering that discusses controversial, hot topics that are affecting biotech. GEN online also provides you with illustrative and instructional Webinars and Application Notes on technology developments. You can also listen to thought-provoking Podcasts, hosted by GEN's editor in chief, John Sterling, and take part in our Polls, which are pick based on high-profile news events.

LAST CHANCE! Strategies for Implementing and Optimizing Informatics and AI for Drug DiscoveryIn this GEN webinar TODAY, ...
06/12/2025

LAST CHANCE! Strategies for Implementing and Optimizing Informatics and AI for Drug Discovery

In this GEN webinar TODAY, three informatics experts—Dimitris Agrafiotis, PhD, Chris Waller, PhD, and Barry Bunin, PhD—discuss how modern informatics platforms and AI technologies can restructure drug research and development workflows in academic labs and pharmaceutical organizations to expedite drug discovery. Register now to join us for this free webinar sponsored by Collaborative Drug Discovery: https://hubs.li/Q03mS25Q0

New Approaches to Ischemia-Reperfusion StudiesHere we examine how alternative in vitro methods that combine atmospheric ...
06/12/2025

New Approaches to Ischemia-Reperfusion Studies

Here we examine how alternative in vitro methods that combine atmospheric control systems with the throughput offered by microplate readers can provide a boost to ischemia-reperfusion research.


Alternatives to in vivo model systems using atmospheric control.

Biomanufacturing Gains as Lab Leasing LagsThe JLL report highlights a clear preference among tenants for high-quality Cl...
06/12/2025

Biomanufacturing Gains as Lab Leasing Lags

The JLL report highlights a clear preference among tenants for high-quality Class A space in prime locations.

The JLL report highlights a clear preference among tenants for high-quality Class A space in prime locations.

How AI is Accelerating the Scientific Method from Trial and Error to Targeted DiscoveryAI is changing the rules of disco...
06/11/2025

How AI is Accelerating the Scientific Method from Trial and Error to Targeted Discovery

AI is changing the rules of discovery. In fact, 98% of life sciences organizations are leveraging generative AI, and 95% use agentic AI—the highest adoption rage among highly regulated industries.

Domino Data Lab

AI will greatly lessen the effort of the discovery process, bringing more novel therapies to the forefront faster than ever before.

Shedding Light on AMR Superbugs: From Penicillin to Photoactivated PrecisionPhotopharmacology combats antimicrobial resi...
06/11/2025

Shedding Light on AMR Superbugs: From Penicillin to Photoactivated Precision

Photopharmacology combats antimicrobial resistance by enabling precise, light-triggered activation of penicillin at infection sites.

University of Groningen

Photopharmacology combats antimicrobial resistance by enabling precise, light-triggered activation of penicillin at infection sites.

Million Species Listing: Basecamp Research Unearths Trove of Sequence Data From Novel SpeciesBaseData aims to improve AI...
06/11/2025

Million Species Listing: Basecamp Research Unearths Trove of Sequence Data From Novel Species

BaseData aims to improve AI models in biology by offering a 10-fold expansion of protein diversity compared to all public databases combined.

BaseData aims to improve AI models in biology by offering a 10-fold expansion of protein diversity compared to all public databases combined.

Smelling Food Activates Neurons That Curb Appetite in Lean MiceScientists at the Max Planck Institute for Metabolism Res...
06/11/2025

Smelling Food Activates Neurons That Curb Appetite in Lean Mice

Scientists at the Max Planck Institute for Metabolism Research found a direct connection from the nose to brain neurons are activated by the smell of food to trigger satiety in lean, but not in obese mice.

A direct connection from the nose to brain neurons are activated by the smell of food to trigger satiety in lean, but not in obese mice.

NEW PODCAST! From Functional Genomics to Cell Therapy: The Role of CRISPR-Based Gene EditingIn this episode, experts wil...
06/11/2025

NEW PODCAST! From Functional Genomics to Cell Therapy: The Role of CRISPR-Based Gene Editing

In this episode, experts will discuss applications of gene editing to improve scientists’ understanding of the relationship between variant and disease in functional genomics studies. They will also talk about the Dharmacon product suite which is designed for CRISPR-based targeted editing in a wide range of cells. LISTEN to this free podcast sponsored by Revvity: https://hubs.li/Q03rkX610

Recursion Eliminating 20% of Workforce, Citing Pipeline Pruning and Capital MarketsRecursion Pharmaceuticals co-founder ...
06/11/2025

Recursion Eliminating 20% of Workforce, Citing Pipeline Pruning and Capital Markets

Recursion Pharmaceuticals co-founder and CEO Chris Gibson posted on LinkedIn and on X that the job cuts were “part of our ongoing commitment to deliver maximal impact from the Recursion 2.0 platform, the maturation of AI tools and ongoing friction in biotech capital markets.”

Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.

Today's the day! Don't forget to register for GEN's State of CRISPR & Genome Editing virtual summit, kicking off at 11am...
06/11/2025

Today's the day! Don't forget to register for GEN's State of CRISPR & Genome Editing virtual summit, kicking off at 11am ET. Hear from industry experts as they discuss the latest scientific, technology, commercial and regulatory advances that will enable genome editing to unleash its full potential in the clinic and beyond.

In his session, Fyodor Urnov PhD reflects on the inspiring "Baby KJ" story and last week's extraordinary meeting between cell and gene therapy scientists and the new FDA/HHS leadership, as the community seeks to try more recipes from the "CRISPR Cures" cookbook.

To register for free, visit:
https://hubs.li/Q03rC2fG0

University of Oxford and ReciBioPharm Expand Malaria Vaccine CollaborationAccording to the WHO, there were an estimated ...
06/11/2025

University of Oxford and ReciBioPharm Expand Malaria Vaccine Collaboration

According to the WHO, there were an estimated 249 million cases of malaria worldwide in 2022, resulting in 608,000 deaths.

World Health Organization (WHO)

According to the WHO, there were an estimated 249 million cases of malaria worldwide in 2022, resulting in 608,000 deaths.

Inspired by Viral Spike Proteins, Multimeric Aptamers Target Protein Complexes with PrecisionInspired by viral attachmen...
06/11/2025

Inspired by Viral Spike Proteins, Multimeric Aptamers Target Protein Complexes with Precision

Inspired by viral attachment to cells, scientists have developed a method for engineering ultra-selective multimeric aptamers.

EPFL

Inspired by viral attachment to cells, scientists have developed a method for engineering ultra-selective multimeric aptamers.

Address

140 Huguenot Street
New Rochelle, NY
10801

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

http://www.linkedin.com/company/genetic-engineering-&-biotechnology-news, http://www.twitter

Alerts

Be the first to know and let us send you an email when Genetic Engineering & Biotechnology News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Genetic Engineering & Biotechnology News:

Share

Category